Search research articles
Contact Us
Filters
Showing results (281-290 of 535) with videos related to
Page
of 54
Sort By:
Current Cancer Drug Targets
|
May 3, 2020
Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia
Vaibhav Agrawal, Olumide B Gbolahan, Maximilian Stahl, et al.
Diabetes Care
|
January 19, 2022
HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial
Anita Y M Kwan, Hertzel C Gerstein, Jan Basile, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
|
October 9, 2023
Toxicity assessment of carvacrol and its acetylated derivative in early staged zebrafish (Danio rerio): Safer alternatives to fipronil-based pesticides?
Isaac Konig, Nazish Iftikhar, Evelyn Henry, et al.
Data in Brief
|
September 20, 2023
Dataset for diseases associated with exposure to broflanilide, a novel pesticide, in larval zebrafish (<i>Danio rerio</i>)
Sarah J Patuel, Cole English, Victoria Lopez-Scarim, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
April 29, 2026
Reusing the workhorse: Outcomes after secondary inset of paraspinous muscle flaps
Parhom Towfighi, Kathryn R Borders, Ryan Harmelink, et al.
The Journal of Surgical Research
|
April 1, 1997
Reducing the deleterious effects of intrauterine CO2 during fetoscopic surgery
Y Saiki, D E Litwin, J L Bigras, et al.
Journal of Vascular Surgery
|
September 29, 2009
Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis: an alternative in patients with contraindications to thrombolysis
Atul S Rao, Gerhardt Konig, Steven A Leers, et al.
Diabetes, Obesity & Metabolism
|
October 26, 2021
A model-based simulation of glycaemic control and body weight when switching from semaglutide to 3.0- and 4.5-mg doses of once-weekly dulaglutide
Lai San Tham, Kevin M Pantalone, Kathleen Dungan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 5, 2022
Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database Study
Anthony R Mato, Lisa M Hess, Yongmei Chen, et al.
Diabetes, Obesity & Metabolism
|
August 4, 2020
Cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists: A comparison of study designs, populations and results
Kevin M Pantalone, Kashif Munir, Clinton M Hasenour, et al.
Page
of 54
Search research articles
Search
Showing results (281-290 of 535) with videos related to
Sort By:
Page
of 54
Current Cancer Drug Targets
|
May 3, 2020
Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia
Vaibhav Agrawal, Olumide B Gbolahan, Maximilian Stahl, et al.
Diabetes Care
|
January 19, 2022
HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial
Anita Y M Kwan, Hertzel C Gerstein, Jan Basile, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
|
October 9, 2023
Toxicity assessment of carvacrol and its acetylated derivative in early staged zebrafish (Danio rerio): Safer alternatives to fipronil-based pesticides?
Isaac Konig, Nazish Iftikhar, Evelyn Henry, et al.
Data in Brief
|
September 20, 2023
Dataset for diseases associated with exposure to broflanilide, a novel pesticide, in larval zebrafish (<i>Danio rerio</i>)
Sarah J Patuel, Cole English, Victoria Lopez-Scarim, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
April 29, 2026
Reusing the workhorse: Outcomes after secondary inset of paraspinous muscle flaps
Parhom Towfighi, Kathryn R Borders, Ryan Harmelink, et al.
The Journal of Surgical Research
|
April 1, 1997
Reducing the deleterious effects of intrauterine CO2 during fetoscopic surgery
Y Saiki, D E Litwin, J L Bigras, et al.
Journal of Vascular Surgery
|
September 29, 2009
Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis: an alternative in patients with contraindications to thrombolysis
Atul S Rao, Gerhardt Konig, Steven A Leers, et al.
Diabetes, Obesity & Metabolism
|
October 26, 2021
A model-based simulation of glycaemic control and body weight when switching from semaglutide to 3.0- and 4.5-mg doses of once-weekly dulaglutide
Lai San Tham, Kevin M Pantalone, Kathleen Dungan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 5, 2022
Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database Study
Anthony R Mato, Lisa M Hess, Yongmei Chen, et al.
Diabetes, Obesity & Metabolism
|
August 4, 2020
Cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists: A comparison of study designs, populations and results
Kevin M Pantalone, Kashif Munir, Clinton M Hasenour, et al.
Page
of 54